NCT07155772 Feasibility Study on a Prehospital Extracorporeal CardioPulmonary Resuscitation in the Pavia's Province.
| NCT ID | NCT07155772 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia |
| Condition | Refractory Cardiac Arrest |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-11-26 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-11-26 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single Center interventional study, assessing the feasibility of a complex treatment strategy where an in-hospital standard care process is applied in an out-of-hospital cardiac arrest. The objective of this study is to investigate the feasibility of a prehospital eCPR program in the context of the Pavia province in order to reduce the time from cardiac arrest to organ reperfusion with thefarthest aim of improving survival and good neurologic outcomes of patient victims of refractory cardiac arrest.
Eligibility Criteria
Inclusion Criteria: * out-of-hospital cardiac arrest occurred in Pavia province * the age of the patient is between 18 and 70 * witnessed cardiac arrest * CPR started within 5 minutes of the patient's collapse or presence of gasping at the arrival of the ACLS team * eCPR team arrived within 60 minutes of the patient's collapse * etCO2 ≥ 10 mmHg * mechanical chest compression is ongoing * refractory cardiac arrest after at least 15 minutes of ACLS Exclusion Criteria: * Modified Rankin Scale (mRS) ≥ 3 * Advanced COPD or other advanced pulmonary illness * End-stage or metastatic neoplasm
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07155772 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Refractory Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07155772 currently recruiting?
Yes, NCT07155772 is actively recruiting participants. Contact the research team at a.palo@smatteo.pv.it for enrollment information.
Where is the NCT07155772 trial being conducted?
This trial is being conducted at Pavia, Italy.
Who is sponsoring the NCT07155772 clinical trial?
NCT07155772 is sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia. The trial plans to enroll 20 participants.